Cover Image

Prostate bed irradiation with alternative radio-oncological approaches (PAROS): a prospective, multicenter and randomized phase III trial

Show other versions (1)

For patients with treatment-naïve carcinoma of the prostate, hypofractionated irradiation becomes more and more popular. Due to the low α/β value of prostate cancer, increased single dose leading to a shortened treatment period seems to be safe and feasible. However, reliable data is lacking for po...

Full description

Saved in:
Bibliographic Details
Main Authors: Körber, Stefan A. (Author) , Katayama, Sonja (Author) , Sander, Anja (Author) , Jäkel, Cornelia (Author) , Häfner, Matthias (Author) , Debus, Jürgen (Author) , Herfarth, Klaus (Author)
Format: Article (Journal)
Language:English
Published: 10 July 2019
In: Radiation oncology
Year: 2019, Volume: 14
ISSN:1748-717X
DOI:10.1186/s13014-019-1325-x
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13014-019-1325-x
Get full text
Author Notes:Stefan A. Koerber, Sonja Katayama, Anja Sander, Cornelia Jaekel, Matthias F. Haefner, Juergen Debus and Klaus Herfarth
Description
Summary:For patients with treatment-naïve carcinoma of the prostate, hypofractionated irradiation becomes more and more popular. Due to the low α/β value of prostate cancer, increased single dose leading to a shortened treatment period seems to be safe and feasible. However, reliable data is lacking for post-prostatectomy patients so far. Further, the role of proton therapy is still under debate. Two prospective phase II trials with both, hypofractionated photon and proton therapy, provided promising results.
Item Description:Gesehen am 01.10.2019
Physical Description:Online Resource
ISSN:1748-717X
DOI:10.1186/s13014-019-1325-x

Similar Items